---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-009478"
form_type: "8-K"
ticker: "CODX"
cik: "0001692415"
company_name: "Co-Diagnostics, Inc."
filed_at: "2026-03-10T23:59:59+00:00"
generated_at: "2026-05-15T16:45:03.218035+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Co-Diagnostics regains Nasdaq compliance; preliminary cash $11.9M as of Dec 31, 2025

## Summary
- Nasdaq notified Co-Diagnostics (CODX) of compliance with $1.00 bid price rule; trading resumes March 11, 2026.
- Nasdaq Hearing Panel closed; one-year Discretionary Panel Monitor imposed through March 9, 2027.
- If bid price falls below $1.00 for 30 consecutive trading days, no 180-day cure period; delist determination possible.
- Preliminary cash and cash equivalents estimated at $11.9M as of December 31, 2025; unaudited and subject to adjustment.

## SEC filing metadata
- accession: 0001493152-26-009478
- form_type: 8-K
- ticker: CODX
- cik: 0001692415
- company_name: Co-Diagnostics, Inc.
- filed_at: 2026-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1692415/000149315226009478/0001493152-26-009478-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1692415/000149315226009478/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-009478
- JSON: https://secwatch.observer/filing/0001493152-26-009478.json
- Plain text: https://secwatch.observer/filing/0001493152-26-009478.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.